Patents by Inventor Marilynn A. Larson

Marilynn A. Larson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF DETECTING AND TYPING PATHOGENIC STRAINS OF FRANCISELLA TULARENSIS
    Publication number: 20230287520
    Abstract: A method of detecting a presence of Francisella tularensis (F. tularensis). The method includes amplifying a first nucleic acid from said specimen using a first plurality of primers, said first plurality of primers comprising SEQ ID NO 4 and SEQ ID NO 5. When the first nucleic acid is detected, then the presence of F. tularensis is determined.
    Type: Application
    Filed: January 9, 2023
    Publication date: September 14, 2023
    Applicant: Government of the United States as Represented by the Secretary of the Air Force
    Inventors: Marilynn A. Larson, James C. Baldwin, Michael P. Dempsey
  • Methods of detecting and typing pathogenic strains of
    Patent number: 11549153
    Abstract: A method of detecting a presence of Francisella tularensis (F. tularensis). The method includes amplifying a first nucleic acid from said specimen using a first plurality of primers, said first plurality of primers comprising SEQ ID NO 4 and SEQ ID NO 5. When the first nucleic acid is detected, then the presence of F. tularensis is determined.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: January 10, 2023
    Assignee: United States of America as represented by the Secretary of the Air Force
    Inventors: Marilynn A. Larson, James C. Baldwin, Michael P. Dempsey
  • METHODS OF DETECTING AND TYPING PATHOGENIC STRAINS OF FRANCISELLA TULARENSIS
    Publication number: 20200332345
    Abstract: A method of detecting a presence of Francisella tularensis (F. tularensis). The method includes amplifying a first nucleic acid from said specimen using a first plurality of primers, said first plurality of primers comprising SEQ ID NO 4 and SEQ ID NO 5. When the first nucleic acid is detected, then the presence of F. tularensis is determined.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 22, 2020
    Applicant: Government of the United States as Represented by the Secretary of the Air Force
    Inventors: Marilynn A. Larson, James C. Baldwin, Michael P. Dempsey
  • METHODS OF DETECTING AND TYPING PATHOGENIC STRAINS OF FRANCISELLA TULARENSIS
    Publication number: 20180327815
    Abstract: A method of detecting a presence of Francisella tularensis (F. tularensis). The method includes amplifying a first nucleic acid from said specimen using a first plurality of primers, said first plurality of primers comprising SEQ ID NO 4 and SEQ ID NO 5. When the first nucleic acid is detected, then the presence of F. tularensis is determined.
    Type: Application
    Filed: February 28, 2018
    Publication date: November 15, 2018
    Applicant: Government of the United States as Represented by the Secretary of the Air Force
    Inventors: Marilynn A. Larson, James C. Baldwin, Michael P. Dempsey
  • Human SAA3 nucleic acid molecule, protein, and methods of use for same
    Patent number: 7368546
    Abstract: A nucleotide sequence encoding human serum amyloid A3 (SAA3), isolated, purified and characterized from human mammary epithelial cells is disclosed. Proteins encoded thereby and methods of use for the same are also disclosed.
    Type: Grant
    Filed: January 21, 2003
    Date of Patent: May 6, 2008
    Assignee: The Board of Regents of the University of Nebraska
    Inventors: Thomas L. McDonald, Marilynn A. Larson, Annika Weber
  • Genomic mammary amyloid a sequence
    Publication number: 20060024804
    Abstract: A genomic nucleotide sequence encoding Serum Amyloid A (SAA), isolated and purified from mammalian colostrum, is disclosed. Methods of use for the same in transgenic protocols is also disclosed.
    Type: Application
    Filed: April 4, 2002
    Publication date: February 2, 2006
    Inventors: Thomas McDonald, Marilynn Larson, Annika Weber
  • Mammary-associated serum amuloid a3 promoter sequences and used for same
    Publication number: 20050107315
    Abstract: Novel colostrum associated mammalian Serum Amyloid A (SAA) promoter sequences are disclosed. These promoters can be used in transgenic protocols for tissue specific expression and expression constructs, vectors and host cells are disclosed. Also the regulatory features of these promoters in colostrum associated SAA productions are exploited to treat disease states associated with or influenced by colostrum associated SAA production.
    Type: Application
    Filed: November 20, 2002
    Publication date: May 19, 2005
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Thomas McDonald, Marilynn Larson, Annika Weber
  • Human SAA3 nucleic acid molecule, protein, and methods of use for same
    Publication number: 20040142415
    Abstract: A nucleotide sequence encoding human serum amyloid A3 (SAA3), isolated, purified and characterized from human mammary epithelial cells is disclosed. Proteins encoded thereby and methods of use for the same are also disclosed.
    Type: Application
    Filed: January 21, 2003
    Publication date: July 22, 2004
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Thomas L. McDonald, Marilynn A. Larson, Annika Weber
  • Genomic mammary amyloid a sequence
    Publication number: 20030170840
    Abstract: A genomic nucleotide sequence encoding Serum Amyloid A (SAA), isolated and purified from mammalian colostrum, is disclosed. Methods of use for the same in transgenic protocols is also disclosed.
    Type: Application
    Filed: April 4, 2002
    Publication date: September 11, 2003
    Inventors: Thomas L. McDonald, Marilynn A. Larson, Annika Weber